Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms

News Back to resource centre 31 May 2022 Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms Cambridge Cognition is pleased to announce that they have joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measure Development project. As a partner of this innovative, collaborative effort, Cambridge Cognition will

Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms Read More »

How CANTAB helps us to explore the cognitive electrophysiology of the deep brain

Insights Back to resource centre 9 August 2022 Generating and validating Verbal Paired Associates word-pair lists for automated testing These posters were presented at the Alzheimer’s Association International Conference on Tuesday 2nd August and Wednesday 3rd August 2022. See below for a summary and to read the full posters. Poster summariesMemorability of Word-Pairs: Developing a Method for Generation of Calibrated

How CANTAB helps us to explore the cognitive electrophysiology of the deep brain Read More »

Investigating the Impact of COVID-19 on Cognition

News Back to resource centre 13 May 2022 Investigating the Impact of COVID-19 on Cognition Children of the 90s collaborates with researchers at Cambridge Cognition to investigate the cognitive impacts of COVID-19.The Children of the 90s health study has collaborated with researchers at Cambridge Cognition, a technology company developing digital health products to assess brain health, to investigate the long-term

Investigating the Impact of COVID-19 on Cognition Read More »

Measuring functional outcomes in schizophrenia in an increasingly digital world

Insights Back to resource centre 9 August 2022 Generating and validating Verbal Paired Associates word-pair lists for automated testing These posters were presented at the Alzheimer’s Association International Conference on Tuesday 2nd August and Wednesday 3rd August 2022. See below for a summary and to read the full posters. Poster summariesMemorability of Word-Pairs: Developing a Method for Generation of Calibrated

Measuring functional outcomes in schizophrenia in an increasingly digital world Read More »

Successful Statistical Strategies for Patient Screening and Stratification

Webinars Back to resource centre 11 January 2023 Successful Statistical Strategies for Patient Screening and Stratification Purposeful consideration of statistical analysis can be hugely beneficial for clinical studies by increasing the potential to detect an efficacy signal and reducing the signal-to-noise ratio. Pre-screening and patient stratification are two methods that can be used to help drive efficiencies and boost the statistical

Successful Statistical Strategies for Patient Screening and Stratification Read More »

Hazardous drinking and cognition in schizophrenia, schizoaffective disorder and bipolar disorder

Insights Back to resource centre 6 April 2022 Hazardous drinking and cognition in schizophrenia, schizoaffective disorder and bipolar disorder We recently caught up with Atiqul Haq Mazumder, a doctoral researcher at the University of Oulu, Finland. Here, he tells us about how he used CANTAB to understand more about whether hazardous drinking could affect cognition in people with schizophrenia, schizoaffective

Hazardous drinking and cognition in schizophrenia, schizoaffective disorder and bipolar disorder Read More »

Electronic Clinical Outcomes Assessment contract win worth over £500,000

News Back to resource centre 16 December 2021 Electronic Clinical Outcomes Assessment contract win worth over £500,000 Cambridge Cognition is pleased to announce that it has won a contract worth over £500,000 to provide electronic clinical outcome assessments (“eCOA”).Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has won a contract

Electronic Clinical Outcomes Assessment contract win worth over £500,000 Read More »

Cambridge Cognition wins £1.0m schizophrenia clinical trial contract

News Back to resource centre 9 December 2021 Cambridge Cognition wins £1.0m schizophrenia clinical trial contract Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has secured a contract for an additional schizophrenia clinical trial worth £1.0m.The revenue from this contract is expected over the next three years. Cambridge Cognition will

Cambridge Cognition wins £1.0m schizophrenia clinical trial contract Read More »

Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPEAD project

Insights Back to resource centre 22 November 2021 Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPEAD project We recently caught up with Dr. Mercè Boada, the project coordinator of MOPEAD, and Medical Director of Ace Alzheimer Center Barcelona to discuss her recent publication supporting the use of CANTAB for the early detection of

Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPEAD project Read More »

Decentralised Trials in Psychiatry: From Feasibility to Novel Insights

Webinars Back to resource centre 11 January 2023 Decentralised Trials in Psychiatry: From Feasibility to Novel Insights As we move towards decentralized and hybrid trial designs, it is increasingly important to understand the feasibility and reliability of digital measurement tools.Here, experts from Otsuka and Cambridge Cognition shared insights from a recent collaborative study, discussing the value of remote monitoring of

Decentralised Trials in Psychiatry: From Feasibility to Novel Insights Read More »

Scroll to Top